Molecules 2013, 18(8), 9670-9683; doi:10.3390/molecules18089670
Review

The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions

1email, 1email, 2email and 2,* email
Received: 14 June 2013; Accepted: 8 August 2013 / Published: 13 August 2013
(This article belongs to the Special Issue Contrast Agents)
Download PDF [410 KB, uploaded 18 June 2014]
Abstract: Inflammation is increasingly being understood to be a key component to the pathophysiology of cerebrovascular lesions. Ferumoxytol, an iron oxide nanoparticle coated by a carbohydrate shell, has been used in MRI studies as an inflammatory marker because it is cleared by macrophages. Ferumoxytol-enhanced MRI has emerged as an important tool for noninvasive assessment of the inflammatory status of cerebrovascular lesions, namely aneurysms and arteriovenous malformations. Moreover, preliminary evidence suggests that ferumoxytol-enhanced MRI could be applied as a non-invasive tool to differentiate “unstable” lesions that require early intervention from “stable” lesions in which observation may be safe. Assessment of the effects of anti-inflammatory pharmacological interventions on cerebrovascular lesions is also a potentially crucial application of the technique. Future improvements in technique and MRI signal quantification will certainly pave the way for widespread and efficient use of ferumoxytol-enhanced MRI in clinical practice. In this paper, we review current data regarding ferumoxytol-enhanced MRI and discuss its current/potential applications and future perspectives.
Keywords: aneurysm; ferumoxytol; arteriovenous malformation; magnetic resonance imaging; inflammation
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Chalouhi, N.; Jabbour, P.; Magnotta, V.; Hasan, D. The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions. Molecules 2013, 18, 9670-9683.

AMA Style

Chalouhi N, Jabbour P, Magnotta V, Hasan D. The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions. Molecules. 2013; 18(8):9670-9683.

Chicago/Turabian Style

Chalouhi, Nohra; Jabbour, Pascal; Magnotta, Vincent; Hasan, David. 2013. "The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions." Molecules 18, no. 8: 9670-9683.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert